Arcadia Biosciences, Inc. (RKDA) — Analysis Summary
Arcadia Biosciences, Inc. (RKDA) has a market cap of $1.36M with year-over-year revenue growth of -3.7%. Net margin stands at -48.1%. The stock trades at a P/E ratio of -0.1.
Key Takeaways
- Revenue changed -3.7% year-over-year
- Net margin of -48.1%
- P/E ratio of -0.1
Compared to other companies in the CRUDE PETROLEUM & NATURAL GAS sector, RKDA posted revenue growth of -3.7% and trades at a P/E of -0.1.
Arcadia Biosciences, Inc. (RKDA)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -200.5x — earnings do not cover interest payments
Operating margin at -80.1% — severe operating losses
Net margin at -195.9% — losses exceed revenue (possible one-time charges)
Net income fell 298.6% vs the prior period.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Sector
CRUDE PETROLEUM & NATURAL GAS
Employees
8
Headquarters
DALLAS, TX
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.